The International Pharmacopoeia

From Wikipedia, the free encyclopedia
Jump to: navigation, search

The aim of The International Pharmacopoeia (Ph. Int.)[1], which is issued by the World Health Organization as a recommendation, is to achieve a wide global uniformity of quality specifications for selected pharmaceutical products, excipients, and dosage forms.

The information published in The International Pharmacopoeia is collated via a consultative procedure and is based on international experience, the monographs being established in an independent manner.

Priority is given to medicines that are widely used throughout the world. High priority is accorded to medicines that are important to WHO health programs, and which may not appear in any other pharmacopoeias, e.g. new antimalarial drugs.

List of the editions[edit]

See also[edit]

External links[edit]